Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme

Cellular and Molecular Neurobiology
Fachen WangBing Chen


Glioblastoma multiforme (GBM) is one of the most malignant cancers. MicroRNAs (miRs) were reported to play important roles in GBM recently. However, the role of a novel miR-186-5p in GBM tumorigenesis is still elusive. Using bioinformatics, miR-186-5p was identified as potential regulators of both fibroblast growth factor (FGF)-2 and NF-κB subunit RelA. Luciferase reporter assay was used to confirm the direct recognition FGF2 and RelA mRNAs by miR-186-5p. Invasion and migration assays were employed to study the effect of miR-186-5p on GBM cell growth in vitro. Xenograft tumor animal model was established to elucidate the in vivo function of miR-186-5p. MiR-186-5p directly targeted mRNAs of both FGF2 and RelA, and repressed their expressions. Invasive and migratory abilities of GBM cells and growth of xenograft tumors were significantly inhibited by miR-186-5p, which can be restored by re-introduction of FGF2 and RelA expressions. MiR-186-5p is a novel tumor suppressor miR that functions to inhibit tumorigenesis of GBM both in vitro and in vivo, by targeting both FGF2 and RelA. MiR-186-5p/FGF2/RelA pathway may be potentially used as molecular targets of in the clinical treatment of GBM.


Oct 27, 2001·Science·M Lagos-QuintanaT Tuschl
Mar 29, 2002·European Journal of Immunology·Ruoxiang WangYufang Shi
Jan 8, 2004·Genome Biology·Anton J EnrightDebora S Marks
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kevin CamphausenPhilip J Tofilon
Oct 10, 2006·Oncogene·J M Cummins, V E Velculescu
Dec 26, 2007·Nucleic Acids Research·Doron BetelChris Sander
Jun 29, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaoli LiHong Zhou
Apr 29, 2014·Cancer Research·Kyung Hee NohTae Woo Kim
Jul 23, 2014·Cancer Research·Andreas HerrmannHua Yu
Sep 30, 2014·Acta Oncologica·Linda SoomanSimon Ekman
Jun 16, 2015·American Journal of Respiratory and Critical Care Medicine·Francesca PolverinoCaroline A Owen
Oct 2, 2015·Cells·Mareike BütepageBernhard Lüscher
Nov 17, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Wei HeGuoqiang Zhao
May 30, 2016·Archivum Immunologiae Et Therapiae Experimentalis·Arvind PandaySanjay Batra
Jun 11, 2016·Cancer Medicine·Amanda SheaDeepak Kumar


May 12, 2018·Bioscience Reports·Lifeng XiaoYuru Li
Jul 6, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cai ZhangYanting Gu
Apr 5, 2019·Cell Proliferation·Xiaodiao KangZhi-Wei Wang
Mar 21, 2020·Frontiers in Oncology·Ying XiangShuai-Shuai Niu

Methods Mentioned

Protein Assay

Related Concepts

RELA protein, human
MIRN186 microRNA, human
Brain Tumor, Recurrent
Glioblastoma Multiforme
Mice, Inbred BALB C
Mice, Nude
Metastasis Suppressor Genes
Fibroblast Growth Factor 2
Xenograft Model Antitumor Assays

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.